Hallmarks of aging

Hallmarks of aging are the cellular and molecular processes that, in the dominant framework of contemporary biogerontology, jointly account for the progressive functional decline of mammals over time. The list was set out as nine hallmarks in a 2013 review in Cell and expanded to twelve by the same five authors in 2023.¹² Each candidate is supposed to satisfy three tests: it manifests during normal aging, experimentally worsening it accelerates aging, and experimentally easing it slows aging and extends healthy life.

§Overview

Human mortality rises close to exponentially with adult age; the annual probability of death roughly doubles every eight years, a regularity described by Benjamin Gompertz in 1825. Beneath that curve sit thousands of measurable changes — shorter telomeres, stiffer arteries, fewer functional stem cells, higher circulating interleukin-6, drifting DNA methylation. The hallmarks framework reduces that inventory to a set of processes that are general across tissues, conserved across mammals, and at least arguably actionable.

The framework does two jobs. It supplies a common vocabulary for a field that had spent decades arguing between rival single-cause theories. It also supplies a target list: most academic programmes and companies in the geroscience sector map their work onto one or more hallmarks, and reviewers treat hallmark membership as prima facie evidence that a mechanism matters. That adoption is itself a fact about the field. The hallmarks are less a discovery than a coordination device that worked.

Terminology

"Hallmark" is borrowed from oncology, where Hanahan and Weinberg used it for capabilities a cell must acquire to become malignant.³ The analogy is imperfect: cancer hallmarks describe what a tumour must do, while aging hallmarks describe what happens to an organism whether or not anything is required of it.

§Origins

Before 2013 the biology of aging was a collection of competing theories, each with a constituency: the free-radical theory, somatic mutation accumulation, error catastrophe, the disposable soma, antagonistic pleiotropy, and telomere shortening. Most were framed as explanations of aging in the singular. Experiments that undercut one theory left the others untouched, and the literature fragmented.

1. 2000
   Hallmarks of Cancer published
   Hanahan and Weinberg condense oncology into six acquired capabilities, demonstrating that a well-chosen list can organize a field.
2. 2013
   Nine hallmarks proposed
   López-Otín, Blasco, Partridge, Serrano and Kroemer publish 'The Hallmarks of Aging' in Cell, grouping nine processes into primary, antagonistic and integrative tiers.
3. 2021
   Paradigm critique
   Gems and de Magalhães argue the framework repackages damage-maintenance thinking and does not distinguish cause from consequence.
4. 2022
   Candidate hallmarks multiply
   A Copenhagen meeting summary proposes further candidates including compromised autophagy, altered mechanical properties and splicing dysregulation.
5. 2023
   Expanded to twelve
   The original authors add disabled macroautophagy, chronic inflammation and dysbiosis, and emphasize the interconnection of the hallmarks.

§What counts as a hallmark

The 2013 paper set three criteria. A hallmark should manifest during normal aging; its experimental aggravation should accelerate aging; and its experimental amelioration should retard aging and extend healthy lifespan. The first criterion is easy — a great many things change with age. The second is harder but tractable, since almost any biological system can be broken in a way that produces a short-lived, sickly animal. The third carries nearly all the weight, and it is where the evidence thins.

Nearly every amelioration result comes from short-lived laboratory organisms: Caenorhabditis elegans, Drosophila, and inbred or genetically heterogeneous mice. No hallmark has been shown to satisfy the third criterion in humans, for the simple reason that no intervention has been demonstrated to slow human aging. Establishing that would require either a multi-decade mortality trial or a surrogate endpoint that regulators accept, which is the problem the field of aging biomarkers exists to solve.

A second difficulty is that accelerating aging and causing disease look alike from outside. Progeroid syndromes — Werner syndrome from WRN mutations, Hutchinson–Gilford progeria from the LMNA variant that produces progerin — recapitulate some features of aging and omit others. Patients with progeria develop severe atherosclerosis but not the cancer or dementia risk of ordinary old age. Whether such syndromes are accelerated aging or a distinct pathology that mimics it remains disputed.

§The twelve hallmarks

The 2013 paper sorted the hallmarks into three tiers by causal position, and the 2023 revision kept the scheme.

§Primary hallmarks: damage

These are unambiguously deleterious processes that accumulate. Genomic instability covers nuclear point mutations, structural variants, and somatic mosaicism, together with damage to mitochondrial DNA. Telomere attrition is treated separately because the end-replication problem gives it a distinct mechanism and a distinct relationship to cancer. Epigenetic alterations include DNA methylation drift, histone modification changes, and loss of heterochromatin, the changes that the epigenetic clocks built by Steve Horvath and others measure. Loss of proteostasis is the failure of the chaperone, proteasome and lysosomal machinery that keeps the proteome folded and turned over. Disabled macroautophagy, added in 2023, separates the autophagic arm of that system into its own hallmark on the grounds that it declines with age across tissues and that genetically raising it extends lifespan in several model organisms — an epistatic and gain-of-function argument in animals, not a demonstration that autophagy can be restored in an aged human.

§Antagonistic hallmarks: responses that turn harmful

These begin as protective and become damaging when chronic or excessive. Deregulated nutrient sensing covers the insulin/IGF-1 axis that Cynthia Kenyon's worm genetics opened up, along with mTOR, AMPK and the sirtuins — signalling that reports abundance and, when persistently activated, suppresses maintenance. It is the node that dietary restriction, Rapamycin and NAD⁺ precursors all address from different directions. Mitochondrial dysfunction describes falling respiratory capacity, altered dynamics and impaired quality control. Cellular senescence is a stable proliferative arrest that suppresses tumours in youth and, through the secretory phenotype of accumulated senescent cells, degrades tissue in age.

§Integrative hallmarks: the phenotype

These are the level at which the organism visibly ages. Stem cell exhaustion is the decline of regenerative capacity in blood, muscle, gut and skin. Altered intercellular communication covers endocrine, neuronal and immune signalling changes, including the systemic factors studied in parabiosis. Chronic inflammation, added in 2023, formalizes Inflammaging as its own hallmark rather than a subtype of communication failure. Dysbiosis, also added in 2023, is the least settled of the twelve; the human microbiome changes with age, but whether those changes cause anything is largely untested outside germ-free and gnotobiotic mice.

§Evidence and use

The strongest support for the framework is indirect: interventions aimed at individual hallmarks extend lifespan in mice, and several do so in genetically heterogeneous mice tested in parallel at multiple independent sites through the National Institute on Aging's Interventions Testing Program. That programme was designed to filter out the single-laboratory, single-strain results that had littered the earlier literature, and its positive findings — rapamycin most robustly, along with acarbose, 17-α-estradiol and canagliflozin, the latter two with effects reported only in males — act mostly on nutrient sensing and metabolic signalling. Senolytic clearance of senescent cells improves physical function in aged mice, and transient expression of reprogramming factors reverses several molecular markers of age in mouse tissues, the approach pursued at scale by reprogramming companies.

None of this has yet produced a human result showing slowed aging rather than improved disease-specific endpoints. The human evidence is almost entirely observational and correlational: methylation-based age estimates predict mortality after adjustment for chronological age, senescent-cell markers rise in aged tissue, and inflammatory markers track frailty. Correlations of that kind are consistent with the hallmarks being causes and equally consistent with their being downstream readouts of something else. The framework is also used prescriptively in a way its authors did not license, as a checklist against which consumer testing panels and supplement formulations are marketed.

Contested

Hallmark membership is not a causal weighting. The framework says which processes belong on the list; it does not say which contribute most to mortality, in what order they act, or which would be worth intervening on first. Several authors argue this is the framework's central omission rather than a detail to be filled in later.

§Criticism

The most sustained critique is that the hallmarks are a taxonomy presented as a theory. Gems and de Magalhães argue that the framework restates the damage-and-maintenance view of aging in new packaging while remaining agnostic on whether each hallmark is a cause, a consequence, or an adaptive response, and that this agnosticism makes it hard to falsify.⁴ Because the hallmarks are heavily interdependent — senescent cells drive inflammation, inflammation impairs stem cell function, impaired stem cell function increases senescent burden — assigning causal priority from the list alone is not possible.

A related objection concerns list inflation. The inclusion criteria are permissive enough that many age-associated processes qualify, and candidate hallmarks have accumulated in the literature faster than the canonical list has been revised.⁵ If the list grows whenever a new mechanism is characterized, it functions as an index of active research areas rather than a constraint on theory.

Alternative frameworks reject the damage-centric premise. Blagosklonny's hyperfunction theory holds that aging is not damage accumulation but the continued, unregulated running of developmental growth programmes after they are needed, with mTOR as the principal driver.⁶ On that account senescence and hypertrophy are the disease, and damage is downstream. A complex-systems view argues that aging emerges from the loss of homeostatic regulation across networks and is not decomposable into discrete mechanisms at all.⁷ SENS, the damage-repair programme associated with Aubrey de Grey, predates the hallmarks and organizes aging into seven categories of accumulated damage on the argument that repair is more tractable than metabolic modulation.

Finally, the framework is mouse-centric in ways that may not transfer. Laboratory mice have long telomeres and constitutive telomerase in many tissues, so telomere attrition means something different in mice than in humans. Species that violate the expected pattern — the negligibly senescent animals such as naked mole-rats and bowhead whales — are not well explained by any tiering of the twelve.

§Outlook

The open problem is converting a list into a ranking. Doing that requires measurements in humans that track the processes rather than their correlates, and interventions selective enough to move one hallmark without moving the others. Both are hard: most candidate drugs hit several hallmarks at once, and most candidate biomarkers are correlational. Prizes and consortia have begun to define outcome measures in terms of functional restoration across muscle, cognition and immunity rather than a molecular readout, precisely because the molecular readouts remain unvalidated as surrogates for Healthspan or lifespan. Until an intervention aimed at a named hallmark changes a hard human endpoint, the framework's central claim — that these processes are the causes of aging rather than its accompaniments — remains an organizing assumption rather than a demonstrated result. Arguments about Biological age reversal and Longevity escape velocity are built on that assumption, and inherit its weakness.

§See also

• Geroscience hypothesis
• Cellular senescence
• Aging biomarkers
• Epigenetic clocks
• Senolytics
• Autophagy
• Caloric restriction
• Negligible senescence
• Biological age

§References